Omics and Computational Modeling Approaches for the Effective Treatment of Drug-Resistant Cancer Cells

Abstract

Chemotherapy is a mainstream cancer treatment, but has a constant challenge of drug resistance, which consequently leads to poor prognosis in cancer treatment. For better understanding and effective treatment of drug-resistant cancer cells, omics approaches have been widely conducted in various forms. A notable use of omics data beyond routine data mining is to use them for computational modeling that allows generating useful predictions, such as drug responses and prognostic biomarkers. In particular, an increasing volume of omics data has facilitated the development of machine learning models. In this mini review, we highlight recent studies on the use of multi-omics data for studying drug-resistant cancer cells. We put a particular focus on studies that use computational models to characterize drug-resistant cancer cells, and to predict biomarkers and/or drug responses. Computational models covered in this mini review include network-based models, machine learning models and genome-scale metabolic models. We also provide perspectives on future research opportunities for combating drug-resistant cancer cells.

From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer

“…Recent findings derived from integrated multi-omics approaches include predictors of clinical response, identification of novel potential drug targets, profiling of compounds and mechanisms leading to drug resistance in different tumor types, and discovery of processes underlying cell plasticity [ 254 , 255 , 256 , 257 ]. This is further complemented by recent advances in medical imagery, where the reliability of pathologic assessment has been much increased by refined molecular imaging techniques, and also by artificial intelligence and machine learning [ 224 , 244 , 258 ].…”

Unraveling the dangerous duet between cancer cell plasticity and drug resistance

“…Computational approaches such as modeling the dynamics of gene regulatory networks, metabolic modeling and machine learning are being increasingly used to study tumor development and suggest new cancer treatment strategies [112]. Metastatic castrate-resistant prostate cancer progression involves a complex circuit involving TGFβ and receptor activator of nuclear kappa β (κβ) ligand, which have shown to possess multiple potential therapeutic targets [113,114].…”

The Impact of Donor and Recipient Genetic Variation on Outcomes After Solid Organ Transplantation: A Scoping Review and Future Perspectives

“…Numerous reviews describing multi-omics approaches to improve diagnostics or treatment for diseases ranging from ovarian cancer to inflammatory bowel disease have been published. [80][81][82] Such a multi-omics approach in the field of transplantation has been coined 'transplant-omics'. As an example, a study combining proteomics and metabolomics delineates which key cellular processes are perturbed in the kidney after brain death.…”